177.00 +0.95 (0.54%)
Pre-Market: 4:49AM EST
|Bid||177.25 x 100|
|Ask||183.80 x 500|
|Day's Range||175.79 - 180.55|
|52 Week Range||160.07 - 256.80|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 6, 2018|
|Forward Dividend & Yield||2.80 (1.59%)|
|1y Target Est||222.81|
OKLAHOMA CITY (AP) — The first trial date has been set for a lawsuit by a state against pharmaceutical companies over the opioid epidemic, according to Oklahoma's attorney general.
Healthcare executives meeting at JP Morgan Conference agree that new tax reform is good, but how it will impact the sector is not yet entirely clear.
Pershing Square Holdings, the hedge fund operated by noted activist investor Bill Ackman, on Wednesday announced it was slashing its management fees, a move related to the settlement of two class-action ...
Also weighing was news overnight that the Bank of Japan had decide to taper its bond purchase program — a major sea change for a central bank that has really typified the extreme post-crisis money printing mentality. In the end, the Dow Jones Industrial Average gained 0.4%, the Nasdaq Composite gained 0.1%, the S&P 500 gained 0.1%, and the Russell 2000 broke the trend to fall 0.1%. Treasury bonds were hit hard, gold declined, and crude oil gained $1.64 to close at nearly $63-a-barrel.
Also weighing was news overnight that the Bank of Japan had decide to taper its bond purchase program — a major sea change for a central bank that has really typified the extreme post-crisis money printing mentality. At the industry level, auto and energy stocks led the way higher with gains of 1.8% and 1.5%, respectively.
COLUMBUS, Ohio (AP) — A federal judge on Tuesday set a goal of doing something about the nation's opioid epidemic this year, while noting the drug crisis is "100 percent man-made."
The Trump administration's tax overhaul should accelerate major acquisitions by drugmakers in 2018 after a slow year for deals in 2017, according to senior executives from some of the largest pharmaceutical manufacturers. The $1.5-trillion bill, which U.S. President Donald Trump signed into law in December, lowers the income tax rate for U.S. companies to 21 percent from 35 percent, encourages them to repatriate cash, and modifies numerous deductions. Brent Saunders, chief executive officer of Allergan Inc (AGN.N), expects tax reform to finally clear the decks for big industry consolidation.
Allergan plc’s (NYSE:AGN) released its most recent earnings update in September 2017, which showed company earnings became less negative compared to the previous year’s level – great news for investorsRead More...
Allergan (AGN) announces weaker-than-expected sales outlook for 2018. A generic version of Restasis is expected to be launched in Q2.
Several companies released updated data on their holiday season, as well as unveiling their guidance for 2018, including A Schulman Inc (NASDAQ:SHLM), Allergan Plc (NYSE:AGN) and Urban Outfitters, Inc. (NASDAQ:URBN). The company announced that it projects its fiscal 2018 earnings to be in the range of $2 to $2.20 per share, compared to the Wall Street consensus estimate of $2.11 per share. A Schulman also reported for its first quarter of the year, announcing earnings of $14.7 million, or 43 cents per share.
Coming off the loss of 1,400 jobs and a foiled patent sidestep, Allergan's CEO says the company's long-term prospects are bright.
Allergan Plc on Monday forecast 2018 revenue below analysts' estimates, hurt by loss of market exclusivity of its products and said it plans to sell its remaining stake in Teva this year. The company also said in a filing that it would record a tax benefit of $3.5 billion to $4 billion related to the U.S. tax reform in the fourth quarter. Allergan said it expects total net revenue of $15.0 billion-$15.3 billion for full-year 2018, compared to analysts' estimates of $15.61 billion, according to Thomson Reuters I/B/E/S.
DUBLIN , Jan. 8, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, is providing its 2018 preliminary financial outlook and other financial updates at the 36th annual ...
DUBLIN, Jan. 8, 2018 /PRNewswire/ -- Allergan plc (AGN) today announced it intends to release fourth quarter and full year 2017 financial results on Tuesday, February 6, 2018, prior to the open of U.S. Financial Markets. Allergan will host a conference call and webcast at 8:30 a.m. Eastern Time on Tuesday, February 6, 2018 to discuss its financial results. The dial-in number to access the call is U.S./Canada (877) 251-7980, International (706) 643-1573, and the conference ID is 67779395.
The crisis could seemingly turn a number of companies on their heads much in the way that big tobacco suits of the late 1990s forever changed the tobacco industry.